Advaxis Inc. sell StockNews.com
Start price
31.03.23
/
50%
€0.059
Target price
31.03.24
-
Performance (%)
-
End price
01.04.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Advaxis Inc. | - | - | - |
| iShares Core DAX® | -1.785% | -1.250% | 11.664% |
| iShares Nasdaq 100 | -2.154% | 0.300% | 37.531% |
| iShares Nikkei 225® | -4.028% | -3.746% | 17.142% |
| iShares S&P 500 | -1.969% | 0.307% | 25.617% |
Comments by StockNews_com for this prediction
In the thread Advaxis Inc. diskutieren
Ayala Pharmaceuticals, Inc. (NASDAQ: ADXS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ADXS provided by MarketBeat
In the thread Trading Advaxis Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten